Algert Global LLC Clearside Biomedical, Inc. Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.49 $5,057 - $9,686	3,890 Added 25.24%	19,300 $28,000
Q1 2022 May 16, 2022	BUY	$1.35 - $2.88 $20,803 - $44,380	15,410 New	15,410 $35,000
Q2 2020 Aug 12, 2020	SELL	$1.55 - $2.41 $39,416 - $61,286	-25,430 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.32 - $3.77 $33,567 - $95,871	25,430 New	25,430 $43,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $64.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.